AKT1 and cancer: It has been proposed that the high glycolytic activity in cancer cells is due to increased activity of Akt [20] and it has been shown that embryonic stem cells have high glycolytic activity in the undifferentiated (tumorigenic) state and lower glycolytic activity in the differentiated (non-tumorigenic) state [21], [22].